Kelun Biotech-B (06990) announced that on June 28, 2024, the company signed an equipment procurement agreement with Kelun Pharmaceutical (002422.SZ), a wholly-owned subsidiary of Kelun Precision. Under the agreement, the company (as the buyer) agrees to purchase and Kelun Precision (as the seller) agrees to sell equipment for RMB 6.24 million.
According to the announcement, the equipment is the equipment that the company plans to purchase from Kelun Precision under the equipment procurement agreement, including about 250 experimental and desk equipment, such as medical low-temperature box, biosafety cabinet, centrifuge, liquid nitrogen tank, cell counter, sterilizer, incubator, drying chamber, medical scale, vacuum pump, electrophoresis instrument, pipette and pipette controller, vortex mixer, inverted microscope, electric hot pot, chromatograph, printer and laptop.
The purchase of equipment is not only in line with the group's research and development needs, but also operates well and is compatible with the group's existing research and development equipment. Once installed, it can be used by the group without major modifications. In addition, the large quantity of purchased equipment enables the group to solve research and development needs on a larger scale and is more convenient and cost-effective than purchasing the same equipment from multiple third-party suppliers. In addition, the group will benefit from Kelun Precision's professional knowledge and resources in the process of purchasing, installing and testing equipment. By completing this purchase, the group's research and development capabilities will be enhanced, ultimately helping to advance the group's drug development and commercialization goals.
The announcement stated that research and development is an important component of the group's business development, and the group is constantly seeking to enhance its internal research and development capabilities. The sale of equipment by Kelun Precision provides the group with an appropriate opportunity to purchase laboratory and desk equipment on a large scale, to strengthen existing research and development capabilities and to improve daily operational efficiency. In addition, the quantity of purchased equipment will enable the group to solve research and development needs on a larger scale, and it is more convenient and cost-effective than purchasing the same equipment from multiple third-party suppliers. In addition, the group will benefit from Kelun Precision's professional knowledge and resources in the process of purchasing, installing and testing equipment. By completing this purchase, the group's research and development capabilities will be enhanced, ultimately helping to advance the group's drug development and commercialization goals.